0001596783-21-000189.txt : 20211103 0001596783-21-000189.hdr.sgml : 20211103 20211103153503 ACCESSION NUMBER: 0001596783-21-000189 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211101 FILED AS OF DATE: 20211103 DATE AS OF CHANGE: 20211103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arnold Jonathan CENTRAL INDEX KEY: 0001721336 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36587 FILM NUMBER: 211375097 MAIL ADDRESS: STREET 1: C/O CATALENT, INC. STREET 2: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Catalent, Inc. CENTRAL INDEX KEY: 0001596783 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208737688 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 BUSINESS PHONE: (732) 537-6200 MAIL ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 FORMER COMPANY: FORMER CONFORMED NAME: PTS Holdings Corp. DATE OF NAME CHANGE: 20140113 4 1 wf-form4_163596808785275.xml FORM 4 X0306 4 2021-11-01 0 0001596783 Catalent, Inc. CTLT 0001721336 Arnold Jonathan C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 0 1 0 0 Pres. Oral & Specialty Deliv. Common Stock 2021-11-01 4 M 0 1962 36.02 A 47046 D Common Stock 2021-11-01 4 M 0 1039 42.23 A 48085 D Common Stock 2021-11-01 4 M 0 2400 43.88 A 50485 D Common Stock 2021-11-01 4 M 0 2158 54.94 A 52643 D Common Stock 2021-11-01 4 S 0 10672 140.02 D 41971 D Options to purchase Common Stock 36.02 2021-11-01 4 M 0 1962 0 D 2027-07-24 Common Stock 1962.0 0 D Options to purchase Common Stock 42.23 2021-11-01 4 M 0 1039 0 D 2027-10-04 Common Stock 1039.0 1042 D Options to purchase Common Stock 43.88 2021-11-01 4 M 0 2400 0 D 2028-07-23 Common Stock 2400.0 2745 D Options to purchase Common Stock 54.94 2021-11-01 4 M 0 2158 0 D 2029-07-22 Common Stock 2158.0 4318 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. Includes restricted stock units. Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1. Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. On July 24, 2017, the reporting person was granted options to purchase 7,839 shares of common stock of the Issuer which vest and become exercisable in four equal annual installments beginning on July 24, 2018. On October 4, 2017, the reporting person was granted options to purchase 4,159 shares of common stock of the Issuer which vest and become exercisable in four equal annual installments beginning on October 4, 2018. The options vest and become exercisable in four equal annual installments beginning on July 23, 2019. The options vest and become exercisable in four equal annual installments beginning on July 22, 2020. /s/ Jose Ibietatorremendia, attorney-in-fact 2021-11-03